期刊文献+

有氧运动对非酒精性单纯性脂肪肝患者胰岛素抵抗的影响 被引量:6

原文传递
导出
摘要 目的探讨有氧运动对绝经前女性非酒精性单纯性脂肪肝患者的胰岛素抵抗的影响。方法选取2009年7-12月在我院健康体检中心诊断为非酒精性单纯性脂肪肝患者100例,均为绝经前女性患者。随机分成基础治疗组和有氧运动组,每组各50例。基础治疗组给予口服维生素C、维生素E、二甲双胍、健康知识宣传教育、改变不良生活方式、低脂饮食等基础治疗。有氧运动组在上述基础治疗同时进行有氧运动。治疗前及治疗后6个月,所有患者采取静脉血检测空腹血糖(FBG)、血清胰岛素(FINS),检查肝脏B超;计算胰岛素抵抗指数(HOMA-IR)。结果与基础治疗组比较,在干预6月后有氧运动组患者的空腹血糖、胰岛素水平和胰岛素抵抗指数明显下降(P<0.05)。结论有氧运动能有效改善绝经前女性非酒精性单纯性脂肪肝患者的空腹血糖、胰岛素水平和胰岛素抵抗。
作者 王彦丽
出处 《实用预防医学》 CAS 2011年第5期939-940,共2页 Practical Preventive Medicine
  • 相关文献

参考文献6

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1515
  • 2Paul A. Nonalcoholic fatty liver disease[J]. N Engl J Med, 2002, 346 (16) : 1221 - 1231.
  • 3Kim HJ, Lee KE, Kim DJ, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults[J ]. Areh Intern Med, 2004,164(19) :2169 - 2175.
  • 4Donati G,Stagni B,Piscagiia F, et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal 1 iver enzymes:role of insulin resistance[J ]. Gut,2004,53(7) : 1020 - 1023.
  • 5YeJ. Role of insulin in the pathogenesis of free fatty acid- induced insulin resistance in skeletal muscle[J]. Endocr Metab Immune Disord Drug Targets, 2007,7 (1) : 65 - 74.
  • 6Wada J. Vaspin: a novel serpin with insulinsensitizing effects[J]. Expert Opin Investig Drugs,2008,17(3) :3272-3273.

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1514

同被引文献97

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部